RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...

The vaccine panel hand-selected by health secretary and anti-vaccine advocate Robert F. Kennedy Jr. on Thursday voted ...

The ACIP is a federal advisory committee composed of medical and public health experts who make recommendations on the use of vaccines for adults and children in the US.

The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.

Both swine and avian influenza are strains of influenza A. Just as swine flu strains tend to infect pigs, avian flu strains ...

The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.

When the seasonal flu strikes, most people expect the familiar lineup of fever, aches and congestion. But for many patients, dizziness emerges as an ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...